These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 35053586)
1. cT1N0M0 Esophageal Squamous Cell Carcinoma Invades the Muscularis Mucosa or Submucosa: Comparison of the Results of Endoscopic Submucosal Dissection and Esophagectomy. Wang CY; Chen BH; Lee CH; Le PH; Tsou YK; Lin CH Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053586 [TBL] [Abstract][Full Text] [Related]
2. Endoscopic submucosal dissection Qian M; Feng S; Zhou H; Chen L; Wang S; Zhang K Therap Adv Gastroenterol; 2022; 15():17562848221138156. PubMed ID: 36458047 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review. Tsou YK; Lee CH; Le PH; Chen BH Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674 [TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma. Kadota T; Sato D; Inaba A; Nishihara K; Takashima K; Nakajo K; Yukami H; Mishima S; Sawada K; Kotani D; Fujiwara H; Nakamura M; Hojo H; Yoda Y; Kojima T; Fujita T; Yano T Esophagus; 2022 Jan; 19(1):153-162. PubMed ID: 34420139 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment. Naito S; Yoshio T; Ishiyama A; Tsuchida T; Tokura J; Namikawa K; Tokai Y; Yoshimizu S; Horiuchi Y; Hirasawa T; Asari T; Mine S; Watanabe M; Ogura M; Chin K; Fukuzawa M; Itoi T; Fujisaki J Dig Endosc; 2022 May; 34(4):793-804. PubMed ID: 34599604 [TBL] [Abstract][Full Text] [Related]
7. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial). Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort. Zhang Y; Ding H; Chen T; Zhang X; Chen WF; Li Q; Yao L; Korrapati P; Jin XJ; Zhang YX; Xu MD; Zhou PH Clin Gastroenterol Hepatol; 2019 Jan; 17(1):73-81.e3. PubMed ID: 29704682 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis. Li J; Wang L; Shi X; Chen J; Jin Z; Zou D; Li Z; Liu F Surg Endosc; 2023 Mar; 37(3):1761-1770. PubMed ID: 36220991 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of endoscopic submucosal dissection versus esophagectomy for poorly differentiated superficial esophageal squamous cell carcinoma: A 10-year cohort study. An W; Pang TT; Sun C; Wang LM; Gao J; Lu CJ; Jiang GX; Wang XW; Zhu J; Yang LX; Chen HZ; Jin H; He MX; Jiang H; Wu C; Luo X; Chen Y; Chen J; Shi XG Dig Liver Dis; 2024 Jun; ():. PubMed ID: 38890059 [TBL] [Abstract][Full Text] [Related]
11. Combined assessment of clinical and pathological prognostic factors for deciding treatment strategies for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa after endoscopic submucosal dissection. Shimada T; Hatta W; Takahashi S; Koike T; Ohira T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Nakamura J; Matsumoto T; Iijima K; Fukuda S; Masamune A; Ito K; Dig Endosc; 2022 Nov; 34(7):1382-1391. PubMed ID: 35702926 [TBL] [Abstract][Full Text] [Related]
12. Comparison of endoscopic submucosal dissection and surgery for superficial esophageal squamous cell carcinoma: a propensity score-matched analysis. Min YW; Lee H; Song BG; Min BH; Kim HK; Choi YS; Lee JH; Hwang NY; Carriere KC; Rhee PL; Kim JJ; Zo JI; Shim YM Gastrointest Endosc; 2018 Oct; 88(4):624-633. PubMed ID: 29750981 [TBL] [Abstract][Full Text] [Related]
13. Endoscopic submucosal dissection versus esophagectomy for early esophageal squamous cell carcinoma with tumor invasion to different depths. An W; Liu MY; Zhang J; Cui YP; Gao J; Wang LP; Chen Y; Yang LX; Chen HZ; Jin H; Liu F; Chen J; Li ZS; Wang LW; Shi XG; Sun C Am J Cancer Res; 2020; 10(9):2977-2992. PubMed ID: 33042630 [TBL] [Abstract][Full Text] [Related]
14. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma. Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070 [TBL] [Abstract][Full Text] [Related]
15. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control. Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa. Uchinami Y; Myojin M; Takahashi H; Harada K; Shimizu S; Hosokawa M Radiat Oncol; 2016 Jun; 11():84. PubMed ID: 27328734 [TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Follow-Up Observation After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa Without Lymphovascular Involvement. Iwai N; Dohi O; Yamada S; Ishida T; Fukui A; Horie R; Yasuda T; Yamada N; Horii Y; Majima A; Zen K; Yagi N; Naito Y; Itoh Y Dig Dis Sci; 2023 Sep; 68(9):3679-3687. PubMed ID: 37470897 [TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and safety between endoscopic submucosal dissection, surgery and definitive chemoradiotherapy in patients with cT1N0M0 esophageal cancer. Luo SA; Sun YY; Zeng YT; Huang CY World J Gastrointest Endosc; 2024 Feb; 16(2):72-82. PubMed ID: 38464816 [TBL] [Abstract][Full Text] [Related]
19. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach. Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Shimizu D; Kimoto T; Shiozaki A; Dohi O; Fujiwara H; Ishikawa T; Konishi H; Naito Y; Otsuji E; Yamada K Radiat Oncol; 2018 Dec; 13(1):246. PubMed ID: 30547811 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy comparison between surgical resection and endoscopic submucosal dissection of early gastric cancer in a domestic single center]. Rong L; Cai Y; Nian W; Wang X; Liang J; He Y; Zhang J Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):190-195. PubMed ID: 29492919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]